Disclaimer

This website is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding one of our products, please report to the Food and Drug Administration (FDA) atand to Roche (Philippines) Inc. Patient Safety via email atThis website is intended for the Philippines only.

Roche (Philippines) Inc. (hereinafter referred to as ""Roche"") is committed to protecting your personal information. Please read more about our Privacy Notice hereYou are aware that Roche has a legal obligation to collect and report potential adverse events brought to its attention to Health Authorities. In such cases, your data will be processed with greatest care and diligence in accordance with specific GVP (pharmacovigilance) legislation, as described in the Privacy Policy related to pharmacovigilanceYour data will not be used for any other purpose.

Roche reserves the right to moderate the contents of this website. At our sole discretion, Roche may review and delete posts, comments, or other feedback that do not comply with the terms of use of this site or local regulations.

For Healthcare Professionals:

Please review product information before prescribing.

Full prescribing information available ator email

For Patients/Lay:

If you need further information, please consult your Healthcare Provider.

For medical information queries and product quality complaints, please email:

For suspected adverse drug reactions, please report to the Food and Drug Administration (FDA) atand to Roche (Philippines) Inc. Patient Safety at

At the first sign of any adverse drug reaction, the patient should seek medical attention immediately.

Date of Production: October 2024

M-PH-00002318